Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/08/2007EP1814595A1 Treatment of cancer with a combination of an agent that perturbs the egf signaling pathway and an oligonucleotide that reduces clusterin levels
08/08/2007EP1814593A1 An oral preparation having improved bioavailability
08/08/2007EP1814592A2 Antiviral composition
08/08/2007EP1814591A1 Bioactive compositions
08/08/2007EP1814589A1 Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
08/08/2007EP1814587A2 Purposeful movement of human migratory cells away from an agent source
08/08/2007EP1814585A2 Methods and materials for the inhibition of transplant rejection
08/08/2007EP1814582A1 A method of reducing drug-induced adverse side effects in a patient
08/08/2007EP1814570A2 Methods for lowering hif-1 medicated gene expression
08/08/2007EP1814562A2 Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
08/08/2007EP1814561A2 Therapeutic furopyrimidines and thienopyrimidines
08/08/2007EP1814560A2 Antibiotic compounds, compositions and medical uses
08/08/2007EP1814559A1 Methods and compositions for protecting cells from ultrasound-mediated cytolysis
08/08/2007EP1814558A2 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
08/08/2007EP1814557A1 Use of a corticosteroid in association with a diuretic and an antacid for the treatment of vascular stenosis and the prevention of vascular restenosis
08/08/2007EP1814556A2 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
08/08/2007EP1814555A1 S-mirtazapine for the treatment of hot flush
08/08/2007EP1814554A1 Certain compounds, compositions, and methods
08/08/2007EP1814553A2 Gtpase inhibitors and use thereof for controlling platelet hyperactivity
08/08/2007EP1814552A2 Compounds for treating protein-kinase mediated disorders
08/08/2007EP1814551A2 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
08/08/2007EP1814550A2 N-sulfonylpiperidine cannabinoid receptor 1 antagonists
08/08/2007EP1814549A2 Method for treating hiv infection through co-administration of tipranavir and uk-427, 857
08/08/2007EP1814548A1 Method for treating hiv infection through co-administration of tipranavir and reverset
08/08/2007EP1814547A1 Method for treating hiv infection through co-administration of tipranavir and darunavir
08/08/2007EP1814546A1 Pharmaceutical composition comprising a macrolide t-cell immunomodulator and anti-photoaging agent
08/08/2007EP1814545A2 Compounds and compositions as protein kinase inhibitors
08/08/2007EP1814544A2 Cancer treatments
08/08/2007EP1814543A2 Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases
08/08/2007EP1814542A2 Novel pharmaceutical compositions and the uses thereof for controlling the different forms of addiction to drugs
08/08/2007EP1814541A2 Stable atorvastatin formulations
08/08/2007EP1814540A2 Compositions useful to treat ocular neovascular diseases and macular degeneration
08/08/2007EP1814539A2 Treatment of conditions caused by calcium abnormalities
08/08/2007EP1814538A2 Method of delivering nasal spray
08/08/2007EP1814537A2 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
08/08/2007EP1814536A1 Copper melphalan and copper tegafur used as anti-tumoral agents
08/08/2007EP1814535A2 Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
08/08/2007EP1814533A2 Behandlung von folgen des alkoholnissbrauchs, hepatitis, pankreatitis
08/08/2007EP1814532A2 Topical application of muscarinic and opioid agents for treatment of tinnitus
08/08/2007EP1814531A2 Transdermal delivery systems
08/08/2007EP1814530A2 Dihydropyrimidine microcapsule-formulations
08/08/2007EP1814528A2 Process for making a highly compressible controlled delivery compositions of metformin
08/08/2007EP1814527A1 Bilayer tablet comprising telmisartan and amlodipine
08/08/2007EP1814526A2 Oral solid dosage forms containing a low dose of estradiol
08/08/2007EP1814520A1 Pharmaceutical compositions comprising a camtothecin derivate
08/08/2007EP1814518A1 Triple natural polymer viscoelastic composition
08/08/2007EP1814517A1 Nonaqueous liquid parenteral aceclofenac formulation
08/08/2007EP1814392A2 Methods and compositions for treating chronic lymphocytic leukemia
08/08/2007EP1814390A2 Methods of treating hematological malignancies with nucleoside analog drugs
08/08/2007EP1740566B1 Hki10311129, novel antibiotic, method for producing the same and the use thereof
08/08/2007EP1709019B1 Thiazole derivatives and use thereof
08/08/2007EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/08/2007EP1692130B1 Phenanthridinium derivatives as dna binding agents
08/08/2007EP1689754B1 42-o-alkoxyalkyl rapamycin derivatives and compositions comprising same
08/08/2007EP1682499B1 4-biarylyl-1-phenylazetidin-2-ones
08/08/2007EP1678180B1 Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors
08/08/2007EP1673055A4 Vegetable substitute for lanolin
08/08/2007EP1664044B1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor
08/08/2007EP1658083B1 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
08/08/2007EP1631285B1 Therapeutic agents useful for treating pain
08/08/2007EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors
08/08/2007EP1596870B1 High dose ibandronate formulation
08/08/2007EP1595537B1 Buccal cavity treatment composition and corresponding uses thereof
08/08/2007EP1587510A4 Method for treating ischemic stroke with melatonin
08/08/2007EP1554264B1 Medicinal arylethanolamine compounds
08/08/2007EP1553950B1 Therapeutic treatment
08/08/2007EP1549303A4 Inhibiting progressive cognitive impairment
08/08/2007EP1546127B1 Novel pyrimidineamide derivatives and the use thereof
08/08/2007EP1539109A4 Block copolymer micelle composition having an enhanced drug-loading capacity and sustained release
08/08/2007EP1532142A4 Polypeptide cleavage process
08/08/2007EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid
08/08/2007EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/08/2007EP1496855A4 Vegetable substitute for lanolin
08/08/2007EP1487832B1 Micronized crystalline tiotropium bromide
08/08/2007EP1482938B1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
08/08/2007EP1480671B1 Recombinant rsv virus expression systems and vaccines
08/08/2007EP1474423B1 Heterocyclic tripeptides as hepatitis c inhibitors
08/08/2007EP1471908B1 Process for preparing losartan potassium with improved flowability
08/08/2007EP1467992B1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
08/08/2007EP1441717B1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
08/08/2007EP1441713B1 Modified release tamsulosin tablets
08/08/2007EP1432705B1 Dual action antibiotics
08/08/2007EP1432681B1 Pseudopolymorphic forms of carvedilol
08/08/2007EP1423124B1 Lyophilized formulation comprising olanzapine
08/08/2007EP1411917B1 Carbamate compounds for use in preventing or treating movement disorders
08/08/2007EP1381595B1 Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients
08/08/2007EP1370233B1 Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound
08/08/2007EP1360169B1 Succinate salt of o-desmethyl-venlafaxine
08/08/2007EP1359902B1 Bimodal dry powder formulation for inhalation
08/08/2007EP1357870B1 Bioadhesive cell foam film of sustained-release delivery
08/08/2007EP1351950B1 Isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
08/08/2007EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage
08/08/2007EP1347979B1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
08/08/2007EP1343530B1 Oral pharmaceutical composition containing a block copolymer
08/08/2007EP1324992B1 Cyclized benzamide neurokinin antagonists for use in therapy
08/08/2007EP1323712B1 Process for producing multiform crystal of donepezil hydrochloride
08/08/2007EP1315509B1 Nitrogen oxide for use in the treatment of drug resistant organisms
08/08/2007EP1280514B1 Evaporative coolant comprising hydrofluorocarbons
08/08/2007EP1277736B1 Novel bicyclic compounds
08/08/2007EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors
1 ... 3636 3637 3638 3639 3640 3641 3642 3643 3644 3645 3646 3647 3648 3649 3650 3651 3652 3653 3654 3655 3656 ... 7860